PUBLISHER: IMARC | PRODUCT CODE: 1541249
PUBLISHER: IMARC | PRODUCT CODE: 1541249
The global photoacoustic imaging market size reached US$ 96.7 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 302.1 Million by 2032, exhibiting a growth rate (CAGR) of 13.09% during 2024-2032.
Photoacoustic imaging, also known as optoacoustic imaging, is a non-invasive biomedical imaging technique that captures images of biological tissues without using ionizing radiation. It is a hybrid modality that functions on the photoacoustic effect, wherein absorbed optical energy is converted into acoustic energy. It offers various advantages over conventional imaging techniques, including high penetration, depth, and image resolution, no harmful ionizing radiation, and molecular targeting at imaging depth. It is employed in detecting physiological properties and naturally occurring chromophores, such as lipids, melanin, hemoglobin concentration, and water and oxygen saturation. Besides this, it is extensively used for tumor mapping, functioning of the brain, detecting skin melanoma, and measuring methemoglobin. As a result, photoacoustic imaging is gaining immense traction across the globe.
The growing geriatric population, which is highly susceptible to various chronic medical disorders, such as diabetes, cardiovascular, neurological, and orthopedic disorders, represents one of the prominent factors positively influencing the market. In addition, the rising prevalence of cancer, coupled with increasing research studies in the field of non-ionizing radiation for imaging, is strengthening the market growth. In line with this, the rising awareness among individuals and healthcare professionals about the early diagnosis and treatment of cancer is offering a favorable market outlook. Furthermore, the photoacoustic imaging technique finds extensive applications in preclinical studies at educational and research institutions, which is offering lucrative growth opportunities to manufacturers. Apart from this, the introduction of advanced technologies by the leading medical equipment manufacturers and research groups is driving the market. Additionally, the expansion of hospitals and laboratory centers is catalyzing the demand for imaging techniques. Moreover, increasing investments by the leading market players in extensive research and development (R&D) activities to launch novel imaging methods are propelling the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global photoacoustic imaging market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, indication, application and end use.
Imaging Systems
Components
Lasers
Transducers
Contrast Agents
Software
Others
Oncology
Cardiology
Neurology
Hematology
Others
Pre-Clinical
Clinical
Hospital and Clinics
Research Institution
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advantest Corporation, Ekspla (EKSMA group), Fujifilm Visualsonics Inc., illumiSonics Inc., InnoLas Laser GmbH, iThera Medical GmbH, kibero GmbH, Litron Lasers Ltd., Opotek LLC, Photosound Technologies Inc., Seno Medical Instruments and Tomowave Laboratories Inc.